ZNF683 (Hobit) Marks a CD8+ T Cell Population Associated with Anti-Tumor Immunity Following Anti-PD-1 Therapy for Richter Syndrome
Camilla Lemvigh
(1, 2)
,
Erin Michelle Parry
(1, 3)
,
Stephanie Deng
(1)
,
Nathan Dangle
(1)
,
Neil Ruthen
(1)
,
Binyamin Knisbacher
(4)
,
Julien Broséus
(5, 6)
,
Sébastien Hergalant
(6)
,
Romain Guieze
(7)
,
Shuqiang Li
(1, 4)
,
Shanye Yin
(1)
,
Teddy Huang
(1)
,
Kenneth Livak
(1)
,
Gad Getz
(4, 3, 8)
,
Donna Neuberg
(1)
,
Pierre Feugier
(9, 6)
,
Peter Kharchenko
(3)
,
William Wierda
(10)
,
Lars Rønn Olsen
(2)
,
Nitin Jain
(10)
,
Catherine Wu
(1, 3, 4)
1
Dana-Farber Cancer Institute [Boston]
2 DTU - Danmarks Tekniske Universitet = Technical University of Denmark
3 HMS - Harvard Medical School [Boston]
4 Broad Institute [Cambridge]
5 CHRU Nancy - Centre Hospitalier Régional Universitaire de Nancy
6 NGERE - Nutrition-Génétique et Exposition aux Risques Environnementaux
7 CHELTER - Role of intra-Clonal Heterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias
8 Massachusetts General Hospital [Boston]
9 Service d'Hématologie [CHRU Nancy]
10 MD Anderson Cancer Center [Houston]
2 DTU - Danmarks Tekniske Universitet = Technical University of Denmark
3 HMS - Harvard Medical School [Boston]
4 Broad Institute [Cambridge]
5 CHRU Nancy - Centre Hospitalier Régional Universitaire de Nancy
6 NGERE - Nutrition-Génétique et Exposition aux Risques Environnementaux
7 CHELTER - Role of intra-Clonal Heterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias
8 Massachusetts General Hospital [Boston]
9 Service d'Hématologie [CHRU Nancy]
10 MD Anderson Cancer Center [Houston]
Sébastien Hergalant
- Fonction : Auteur
- PersonId : 18401
- IdHAL : sebastien-hergalant
- ORCID : 0000-0001-8456-7992